Review Article: Vitamin C Progress Apoptosis in Breast Cancer
The cancer of breast is virulence in female and is curable in ~70–80% of patients. The vitamin type C is an essential vitamin and consider as an anti-oxidant, so this vitamin could recover the supply for oxygen, stopping the destroy of DNA and other impact necessary in cancer processing. The vitamin C indicate as an active anticancer as the concentricity were monitor in this cancer therapy. The concentricity of this vitamin has a main function in cancer-rising or cancer suppression. These studies have shown a relationship between the vitamin and increase death-rate of breast cancer, so it’s important to detect the anticancer prospective of vitamin C to detect the different among its effect in healthy and damage cells, especially these studies conducted that this difference could depend on the vitamin c concentration. These studies indicate that large doses of vitamin c could decrease the effect of some cancer therapy such as radiation and chemotherapy.
Granger M. and Eck P., 2018. “Dietary vitamin C in human health” Advances in food and nutrition research, vol. 83, pp. 281–310,
Jackson J, Riordan HD, Hunninghake R, Riordan N.,1995. “High dose intravenous vitamin c and long-time survival of a patient with cancer of the head of the pancreas”. J. Orthomolec Med 10: 87-88.
Ang A., Pullar J., Currie M. and Vissers M., 2018. “Vitamin C and immune cell function in inflammation and cancer,” J. Biochemical Society transactions, vol. 46, no. 5, pp. 1147–1159.
Duconge J., Miranda-Massari J., Gonzalez M., Riordan N., Riordan H., 2007. “Vitamin C Pharmacokinetics after Continuous IV Infusion in a Patient with Prostate Cancer”. J. Ann Pharmacother; 41: 1082-1083
Carr A., Bozonet S., Pullar J., Simcock J. and Vissers M., 2013. “A randomized steady-state bioavailability study of synthetic versus natural (kiwifruit-derived) vitamin C”. J. Nutrients, vol. 5, no. 9, pp. 3684–3695,
Sun Q., Lesperance J., Wettersten H.,2018. “Proapoptotic PUMA targets stem-like breast cancer cells to suppress metastasis”. J. Clin Invest;128(1):531–544. doi:10.1172/JCI93707
Yang G., Yan Y., Ma Y., Yang Y. 2017 “Vitamin c at high concentrations induces cytotoxicity in malignant melanoma but promotes tumor growth at low concentrations.” Mol Carcinog; 56(8):
Padayatty S., Sun H., Wang Y., Riordan H., Hewitt S., Katz A., Wesley R. and Levine M., 2004 “Vitamin c pharmacokinetics: Implications for oral and intravenous use”. J. Ann Intern Med; 140:(7): 533-537, 2004.
Elzbieta P., Joanna S., and Janusz B. Pro- and Antioxidant Effects of Vitamin C in Cancer in correspondence to Its Dietary and Pharmacological Concentrations Elzbieta.” Oxidative Medicine and Cellular Longevity Volume 2019, Article ID 7286737, 18 pages.
Vissers M. and Das A. “Potential mechanisms of action for vitamin C in cancer”: reviewing the evidence,” Frontiers in physiology, vol. 9, p. 809, 2018
Sawsan H., Roaa M., Apoptosis and necrosis of human breast cancer cells by an aqueous extract of garden cress (Lepidium sativum) seeds. Saudi Journal of Biological Sciences (2013) 20, 131–139
Ye M., Pang N. and Wan T. et al., “Oxidized vitamin C (DHA) overcomes resistance to EGFR-targeted therapy of lung cancer through disturbing energy homeostasis,” Journal of Cancer, vol. 10, no. 3, pp. 757–764, 2019.
Zou W., Yue p., Lin N. et al., “Vitamin C inactivates the proteasome inhibitor PS-341 in human cancer cells,” Clinical cancer research: an official journal of the American Association for Cancer Research, vol. 12, no. 1, pp. 273–280, 2006.
Karazhiyan, H., Razavi, S.M.A., Phillips, G.O., Fang, Y., Al-Assaf, S., Nishinari, K., Farhoosh, R., 2009. Rheological properties of Lepidium sativum seed extract as a function of concentration, temperature and time. Food Hydrocolloids 23, 2062–2068.
Wojdyo A., Oszmian´s., Czemerys J. 2007. Antioxidant activity and phenolic compounds in 32 selected herbs. Food Chemistry 105, 940–949
Greenlee, H. et al. Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort. Cancer. 118, 2048–58 (2012).
Hao C., Wang Z., Gu Y., Jiang W. and Cheng S. Prognostic value of osteopontin splice variant-c expression in breast cancers: a meta-analysis. Biomed Res Int. 2016:7310694. doi:10.1155/2016/7310694
Kim J., Kang J., Lee W.: Vitamin c induces apoptosis in human colon cancer cell line, hct-8 via the modulation of calcium influx in endoplasmic reticulum and the dissociation of bad from 14-3-3 beta. Immune Netw 12(5): 189-195, 2012.
Hoffer L., Robitaille L., Zakarian R., Melnychuk D., Kavan P., Agulnik J., Cohen V., Small D.and Miller W. High-dose intravenous vitamin c combined with cytotoxic chemotherapy in patients with advanced cancer: A phase i-ii clinical trial. PLoS One 10(4): e0120228, 2015. Google Scholar
Shiovitz, S. & Korde, L. A. Genetics of breast cancer: a topic in evolution. Ann. Oncol. 26, 1291–1299 (2015).
Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008–2030): apopulation-based study. Lancet Oncol. 2012; 13(8):790–801. doi:10.1016/S1470-2045(12)70211-5
Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease. Lancet 358,1389–1399 (2001).
Brewer, H. R., Jones, M. E., Schoemaker, M. J., Ashworth, A. & Swerdlow, A. J. Family history and risk of breast cancer: an analysis accounting for family structure. Breast Cancer Res. Treat. 165, 193–200 (2017).
Bray, F. et al. Cancer Incidence in Five Continents: inclusion criteria, highlights from Volume X and the global status of cancer registration. Int. J. Cancer137, 2060–2071 (2015).
Mariotto, A. B., Etzioni, R., Hurlbert, M., Penberthy, L.& Mayer, M. Estimation of the number of women living with metastatic breast cancer in the United States. Cancer Epidemiol. Biomark. Prev. 26, 809–815 (2017).
Althuis, M. D., Dozier, J. M., Anderson, W. F., Devesa, S. S. & Brinton, L. A. Global trends in breast cancer incidence and mortality 1973–1997. Int. J. Epidemiol. 34, 405–412 (2005).
Colditz, G. A., Sellers, T. A. & Trapido, E. Epidemiology— identifying the causes and preventability of cancer. Nat. Rev. Cancer 6, 75–83 (2006).
Ruffell, B. et al. Leukocyte composition of human breast cancer. Proc. Natl Acad. Sci. USA 109,2796–2801 (2012).
Independent, U. K. Panel on breast cancer screening. The benefits and harms of breast cancer screening: an independent review. Lancet 380, 1778–1786 (2012).
Srigley, J. R. et al. Standardized synoptic cancer pathology reporting: a population- based approach. J. Surg. Oncol. 99, 517–524 (2009).
Nelson, H. D. et al. Effectiveness of breast cancer screening: systematic review and meta- analysis to update the 2009 U.S. Preventive Services Task Force recommendation. Ann. Intern. Med. 164, 244–255 (2016).
World Heath Organisation. WHO Classification of Tumours of the Breast, Fourth Edition. (World Health Organization, 2012).
Elston, C. W. & Ellis, I. O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long- term follow- up. Histopathology 19,403–410 (1991).
Amin, M. B. et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population- based to a more ‘personalized’ approach to cancer staging. CA Cancer J. Clin. 67, 93–99(2017).
Irwig, L., Macaskill, P. & Houssami, N. Evidence relevant to the investigation of breast symptoms: the triple test. Breast 11, 215–220 (2002).
Copyright (c) 2021 International Journal for Research in Applied Sciences and Biotechnology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.